Cargando…
Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study
BACKGROUND: Australia commenced human papillomavirus (HPV) vaccination in 2007, with a two-year catch-up to the age of 26; catch-up cohorts are thus now entering their thirties. Plans for monitoring vaccine impact involve pre- and post-vaccination assessment of cervical HPV DNA in the general popula...
Autores principales: | Velentzis, Louiza S, Sitas, Freddy, O’Connell, Dianne L, Darlington-Brown, Jessica, Egger, Sam, Sinha, Rohit, Banks, Emily, Frazer, Ian H, Canfell, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299782/ https://www.ncbi.nlm.nih.gov/pubmed/25528152 http://dx.doi.org/10.1186/s12879-014-0676-z |
Ejemplares similares
-
Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study
por: Velentzis, Louiza S., et al.
Publicado: (2016) -
Menopausal hormone therapy: Characterising users in an Australian national cross-sectional study
por: Velentzis, Louiza S., et al.
Publicado: (2021) -
Injectable and Oral Contraceptive Use and Cancers of the Breast, Cervix, Ovary, and Endometrium in Black South African Women: Case–Control Study
por: Urban, Margaret, et al.
Publicado: (2012) -
Accurate categorisation of menopausal status for research studies: a step-by-step guide and detailed algorithm considering age, self-reported menopause and factors potentially masking the occurrence of menopause
por: Yap, Sarsha, et al.
Publicado: (2022) -
Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations
por: Velentzis, Louiza S., et al.
Publicado: (2017)